RecruitingNCT05705219

Development of 3D Multi-Parametric Ultrasound (MPUS) as a Decision Support Tool for Patients

Development of 3D Multi-Parametric Ultrasound (MPUS) as a Decision Support Tool for Patients With Abdominal and Pelvic Tumors Undergoing Therapy

Sponsor

University of California, San Diego

Enrollment

80 participants

Start Date

Dec 4, 2023

Study Type

OBSERVATIONAL

Conditions

Liver Cancer, Adult

Summary

This clinical trial studies how well 3-dimensional multi-parametric ultrasound (3D MPUS) imaging works as a decision-support tool for patients with liver tumors undergoing therapy. Continuous and dynamic imaging of patients undergoing therapy is required to monitor early-phase treatment response.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is developing and testing advanced 3D ultrasound imaging — using multiple ultrasound parameters at the same time — to monitor how liver metastases (secondary tumors in the liver that originated from colorectal cancer) respond to cancer treatment, providing an alternative to CT or MRI scans. **You may be eligible if...** - You are 18 or older - You have liver metastases from colorectal cancer (confirmed by biopsy or characteristic imaging) - You are about to start a new course of cancer treatment - You have at least one liver lesion that is 1 cm to 14 cm in diameter - You are willing to participate and have given written consent **You may NOT be eligible if...** - You have had a severe allergic reaction to ultrasound contrast agents or to polyethylene glycol (PEG) - You have other conditions that make the ultrasound procedure unsafe Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.